MP417IMPACT OF INTRAVENOUS FERRIC CARBOXYMALTOSE IRON THERAPY ON SYMPTOMS AND FUNCTIONALITY IN IRON-DEFICIENT PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION AND RENAL DYSFUNCTION: AN INDIVIDUALPATIENT DATA META-ANALYSIS OF 4 RANDOMIZED, DOUBLE-BLIND TRIALS | Publicación